Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7285-7292, Vol. 69, No. 12
Laboratory of Parasitic Diseases, National
Institute of Animal Health, National Agricultural Research
Organization, Tsukuba, Ibaraki 305-0856,1
Laboratory of Global Animal Resource Science, Graduate School
of Agricultural Life Science, University of Tokyo, Yayoi, Bunkyo, Tokyo
113-8657,2 Department of Parasitology,
School of Medicine, University of the Ryukyus, Uehara, Nishihara,
Tyuto, Okinawa 903-0215,3 and Department
of Parasitology, Miyazaki Medical College, Miyatake, Miyazaki
889-16,4 Japan
Received 29 May 2001/Returned for modification 6 August
2001/Accepted 24 September 2001
Animals can be rendered immune to Ascaris parasites by
immunization with infectious-stage larvae. The specific parasite gene products that mediate protective responses in ascariasis are unknown. We have identified a cDNA encoding Ascaris suum 14-kDa
antigen (As14) and evaluated the vaccinal effect of the
Escherichia coli-expressed recombinant protein (rAs14).
GenBank analysis showed that As14 has low similarity at the amino acid
level to a Caenorhabditis elegans gene product and to
antigens of the filarial nematodes but not to other known proteins. In
addition, As14 homologues were found to be expressed in human and dog
roundworms. In mice that received intranasal administration of rAs14
coupled with cholera toxin B subunit (rAs14-CTB), there was a 64%
reduction of recovery of larvae compared with that in the nontreated
group. The vaccinated mice showed a significant increase in the total serum immunoglobulin G (IgG) levels and the mucosal IgA responses. Elevation of the rAs14-specific IgE response was also seen. Measurement of the IgG subclasses showed a higher level of IgG1 and a lower level
of IgG2a antibody response in the sera of the immunized mice,
suggesting that protection was associated with a type II immune
response. As14 is the first protective antigen against A. suum infection to be identified. Our immunization trial results in laboratory animals suggest the possibility of developing a mucosal
vaccine for parasitic diseases caused by ascarid nematodes.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7285-7292.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Intranasal Immunization with Recombinant Ascaris suum
14-Kilodalton Antigen Coupled with Cholera Toxin B Subunit Induces
Protective Immunity to A. suum Infection in Mice
*
Corresponding author. Mailing address: Laboratory of
Parasitic Diseases, National Institute of Animal Health, National
Agricultural Research Organization, 3-1-5 Kannondai, Tsukuba, Ibaraki
305-0856, Japan. Phone: 81-298-38-7749. Fax: 81-298-38-7880. E-mail:
tsujin{at}niah.affrc.go.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»